Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Nelson

Showing results (971-980 of 1,126) with videos related to

Pageof 113
Sort By:
Epigenetics|October 31, 2012
Epigenetic biomarkers of T-cells in human gliomaJohn K Wiencke, William P Accomando, Shichun Zheng, et al.
Cancer Immunology, Immunotherapy : CII|December 2, 2021
MAIT cells accumulate in ovarian cancer-elicited ascites where they retain their capacity to respond to MR1 ligands and cytokine cuesTony Yao, Patrick T Rudak, Céline M Laumont, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 22, 2017
Enhancing the Infrastructure of the Atherosclerosis Risk in Communities (ARIC) Study for Cancer Epidemiology Research: ARIC CancerCorinne E Joshu, John R Barber, Josef Coresh, et al.
Therapeutic Advances in Medical Oncology|May 12, 2025
Xevinapant plus avelumab in advanced solid tumours, with a dose expansion in advanced non-small-cell lung cancer: exploratory biomarker, safety and efficacy analyses from an open-label, nonrandomised phase Ib studyGlenwood Goss, Tudor Ciuleanu, Rodryg Ramlau, et al.
American Journal of Human Genetics|August 29, 2001
The frequency of hereditary defective mismatch repair in a prospective series of unselected colorectal carcinomasJ M Cunningham, C Y Kim, E R Christensen, et al.
Cancer Research|June 21, 2020
IL6 Fuels Durable Memory for Th17 Cell-Mediated Responses to TumorsHannah M Knochelmann, Connor J Dwyer, Aubrey S Smith, et al.
Cancer Research Communications|March 13, 2023
Tumor-derived GCSF Alters Tumor and Systemic Immune System Cell Subset Composition and SignalingIsrael Matos, Maunish Barvalia, Manreet K Chehal, et al.
Plos Genetics|August 15, 2009
Aging and environmental exposures alter tissue-specific DNA methylation dependent upon CpG island contextBrock C Christensen, E Andres Houseman, Carmen J Marsit, et al.
Infection Control and Hospital Epidemiology|January 29, 2015
Validation of an automated surveillance approach for drain-related meningitis: a multicenter studyMaaike S M van Mourik, Annet Troelstra, Jan Willem Berkelbach van der Sprenkel, et al.
The Journal of Pathology|April 14, 2025
Activated immune infiltrates expand opportunities for targeted therapy in p53-abnormal endometrial carcinomaSpencer D Martin, Shelby Thornton, Christine Chow, et al.
Pageof 113

Showing results (971-980 of 1,126) with videos related to

Sort By:
Pageof 113
Epigenetics|October 31, 2012
Epigenetic biomarkers of T-cells in human gliomaJohn K Wiencke, William P Accomando, Shichun Zheng, et al.
Cancer Immunology, Immunotherapy : CII|December 2, 2021
MAIT cells accumulate in ovarian cancer-elicited ascites where they retain their capacity to respond to MR1 ligands and cytokine cuesTony Yao, Patrick T Rudak, Céline M Laumont, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 22, 2017
Enhancing the Infrastructure of the Atherosclerosis Risk in Communities (ARIC) Study for Cancer Epidemiology Research: ARIC CancerCorinne E Joshu, John R Barber, Josef Coresh, et al.
Therapeutic Advances in Medical Oncology|May 12, 2025
Xevinapant plus avelumab in advanced solid tumours, with a dose expansion in advanced non-small-cell lung cancer: exploratory biomarker, safety and efficacy analyses from an open-label, nonrandomised phase Ib studyGlenwood Goss, Tudor Ciuleanu, Rodryg Ramlau, et al.
American Journal of Human Genetics|August 29, 2001
The frequency of hereditary defective mismatch repair in a prospective series of unselected colorectal carcinomasJ M Cunningham, C Y Kim, E R Christensen, et al.
Cancer Research|June 21, 2020
IL6 Fuels Durable Memory for Th17 Cell-Mediated Responses to TumorsHannah M Knochelmann, Connor J Dwyer, Aubrey S Smith, et al.
Cancer Research Communications|March 13, 2023
Tumor-derived GCSF Alters Tumor and Systemic Immune System Cell Subset Composition and SignalingIsrael Matos, Maunish Barvalia, Manreet K Chehal, et al.
Plos Genetics|August 15, 2009
Aging and environmental exposures alter tissue-specific DNA methylation dependent upon CpG island contextBrock C Christensen, E Andres Houseman, Carmen J Marsit, et al.
Infection Control and Hospital Epidemiology|January 29, 2015
Validation of an automated surveillance approach for drain-related meningitis: a multicenter studyMaaike S M van Mourik, Annet Troelstra, Jan Willem Berkelbach van der Sprenkel, et al.
The Journal of Pathology|April 14, 2025
Activated immune infiltrates expand opportunities for targeted therapy in p53-abnormal endometrial carcinomaSpencer D Martin, Shelby Thornton, Christine Chow, et al.
Pageof 113